AEON

AEON Biopharma, Inc. AEON

AEON
AEON Biopharma, Inc. INTS
Intensity Therapeutics, Inc. MBRX
Moleculin Biotech, Inc. IBIO
iBio, Inc. CTXR
Citius Pharmaceuticals, Inc. ATHA
Athira Pharma, Inc. TRAW
Traws Pharma, Inc. IMNN
Imunon, Inc. THAR
Tharimmune, Inc. BRTX
BioRestorative Therapies, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AEON INTS MBRX IBIO CTXR ATHA TRAW IMNN THAR BRTX
6M 170.27 % -85.50 % -39.93 % -22.77 % 39.00 % 56.54 % 32.86 % -63.55 % 174.78 % -10.11 %
YTD -97.22 % -84.17 % -71.19 % -64.90 % -64.18 % -32.55 % -67.36 % -69.52 % 54.15 % 7.38 %
1Y -98.50 % -91.50 % -78.11 % -69.77 % -85.13 % -16.44 % -41.04 % -67.87 % 63.73 % -7.51 %
3Y -99.83 % -95.35 % -96.56 % -98.19 % -95.08 % -89.40 % -83.59 % -79.62 % -98.72 % -51.22 %
5Y -99.83 % -95.35 % -99.30 % -99.92 % -94.75 % -97.96 % -97.48 % -96.61 % -99.76 % -97.37 %
10Y -99.83 % -95.35 % -99.93 % -99.98 % -99.70 % -97.83 % -100.00 % -99.92 % -99.76 % -99.99 %
From the beginning -99.83 % -95.35 % -99.93 % -99.98 % -99.63 % -97.83 % -100.00 % -100.00 % -99.76 % -100.00 %

Dividend